Follow-up award supports commercialization for healthcare data interoperability
GLENDALE, CA – October 18, 2023 – emTRUTH®, whose mission is to help healthcare companies unlock the full value of their data, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant to continue Phase II of their research and development (R&D) work.
Data security and interoperability continue to be paramount concerns in the ever-evolving healthcare landscape. It can be challenging and cost-prohibitive to combine data from various systems with different formats and sizes. emTRUTH’s work focuses on the advancements of blockchain and artificial intelligence (AI) technology to make healthcare data flow seamless, searchable and more secure. Doing so can make data-sharing a more efficient process and improve patient care.
This is the second year that emTRUTH has been awarded an NSF grant. In 2022, the organization was awarded a Phase I SBIR grant. As part of Phase I, emTRUTH proved its prototype solution can simplify the mechanics of data integration and interoperability to improve analytics, diagnostics and discovery.
“We are thrilled to once again receive this prestigious award from the National Science Foundation,” said Irene Woerner, CEO of emTRUTH. “This recognition is a testament to our unwavering commitment to revolutionize healthcare data interoperability. At emTRUTH, we believe in the power of technology to make data seamless, secure and readily accessible. With this grant, we take a significant step forward in delivering innovative solutions to the healthcare industry.”
The Phase II grant supports emTRUTH, and its leading academic, healthcare provider and medical non-profit collaborators, as they begin building production-ready beta pilots. These pilots will address the distinct and high priority pain points of different healthcare customers and provider stakeholders. With all data secured in blockchain, features will include:
Syntactic and semantic normalization of various data types
Patient consent for secure data sharing with an easy-to-use web and mobile app
Different levels of sharing the right data, with the right people, the right time
On-demand analytics capabilities to leverage existing analytics tools
The project focuses on priority use cases to showcase how data needs to become interoperable. Such use cases include sharing patient clinical data for research, creating more comprehensive patient healthcare records, bridging an operational gap between clinical data and claims, and supporting collaboration in treating complex diseases.
“We are excited to embark on the next phase of our journey with the support of this grant,” Woerner said. “We are committed to addressing real-world healthcare challenges related to data and interoperability.”
About the National Science Foundation's Small Business Programs
America’s Seed Fund powered by NSF awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $2 million to support research and development (R&D), helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $8.5 billion that supports fundamental research and education across all fields of science and engineering.
About emTRUTH
emTRUTH® unlocks the power of healthcare data. We do this by making it quick and easy for healthcare providers (who are not IT experts) to securely combine and share data on demand while they and their patients retain full ownership and control of their data. The company’s patented API offers fast and secure horizontal or vertical data integration and interoperability of any type of data, from anywhere, using any standard, to any app. In days, not months, for less. For more information, visit www.emtruth.com.
Contact
Irene Woerner, CEO
+1.626.790.8268